( August 29, 2025, 8:26 AM EDT) -- NEW YORK — A federal court properly found that the marketing and pricing claims alleging that Johnson & Johnson Consumer Inc. (JJCI) improperly advertised that its Tylenol Rapid Release Gelcaps worked faster than cheaper tablet alternatives are preempted by federal law, the Second Circuit U.S. Court of Appeals held....